ORCID as entered in ROS

Select Publications
Thanos SM; Halliday GM; Damian DL, 2012, 'Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans', BRITISH JOURNAL OF DERMATOLOGY, 167, pp. 631 - 636, http://dx.doi.org/10.1111/j.1365-2133.2012.11109.x
Huang Y; Chegini F; Chua G; Murphy K; Gai W; Halliday GM, 2012, 'Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation', Translational Neurodegeneration, 1, http://dx.doi.org/10.1186/2047-9158-1-2
Fu Y; Yuan Y; Halliday GM; Rusznak Z; Watson C; Paxinos G, 2012, 'A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse', Brain Structure and Function, 217, pp. 591 - 612, http://dx.doi.org/10.1007/s00429-011-0349-2
Wong J; Higgins M; Halliday GM; Garner B, 2012, 'Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease', Neuroscience, 210, pp. 363 - 374, http://dx.doi.org/10.1016/j.neuroscience.2012.02.037
Lewis SJG; Shine JM; Duffy S; Halliday GM; Naismith SL, 2012, 'Anterior cingulate integrity: Executive and neuropsychiatric features in Parkinson's disease', Movement Disorders, 27, pp. 1262 - 1267, http://dx.doi.org/10.1002/mds.25104
Huang Y; Halliday GM, 2012, 'Aspects of innate immunity and Parkinson's disease', Frontiers in Pharmacology, 3, pp. Art. No. 33, http://dx.doi.org/10.3389/fphar.2012.00033
Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok J, 2012, 'C9ORF72 repeat expansion in clinical and neuropathological frontotemporal dementia cohorts', Neurology, 79, pp. 995 - 1001
Kim WS; Halliday , 2012, 'Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression', Journal of Parkinson's Disease, 2, pp. 41 - 46, http://dx.doi.org/10.3233/JPD-2012-11059
Sarchio SNE; Kok L-F; O'Sullivan C; Halliday GM; Byrne SN, 2012, 'Dermal mast cells affect the development of sunlight-induced skin tumours', EXPERIMENTAL DERMATOLOGY, 21, pp. 241 - 248, http://dx.doi.org/10.1111/j.1600-0625.2012.01438.x
Halliday GM; Mccann H; Shepherd CE, 2012, 'Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?', Expert Review of Neurotherapeutics, 12, pp. 673 - 686, http://dx.doi.org/10.1586/ern.12.47
Reyes S; Fu Y; Double KL; Thompson L; Kirik D; Paxinos G; Halliday GM, 2012, 'GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area', Journal of Comparative Neurology, 520, pp. 2591 - 2607, http://dx.doi.org/10.1002/cne.23051
Hornberger M; Wong S; Tan R; Irish M; Piguet O; Kril J; Hodges JR; Halliday GM, 2012, 'In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease', Brain, 135, pp. 3015 - 3025, http://dx.doi.org/10.1093/brain/aws239
Shine JM; Halliday GM; Carlos M; Lewis SJG; Naismith S, 2012, 'Investigating visual misperceptions in Parkinson's disease: A novel behavioral paradigm', Movement Disorders, 27, pp. 500 - 505, http://dx.doi.org/10.1002/mds.24900
Sharpe LJ; Wong J; Garner B; Halliday GM; Brown AJ, 2012, 'Is seladin-1 really a selective Alzheimer's disease indicator?', Journal of Alzheimer's Disease, 30, pp. 35 - 39, http://dx.doi.org/10.3233/JAD-2012-111955
Elliott DA; Kim WS; Gorissen SV; Halliday GM; Kwok J, 2012, 'Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease', Movement Disorders, 27, pp. 1004 - 1011, http://dx.doi.org/10.1002/mds.25005
Halliday GM; Bigio EH; Cairns NJ; Neumann M; Mackenzie IRA; Mann DM, 2012, 'Mechanisms of disease in frontotemporal lobar degeneration: Gain of function versus loss of function effects', ACTA Neuropathologica, 124, pp. 373 - 382, http://dx.doi.org/10.1007/s00401-012-1030-4
Valenzuela MJ; Matthews F; Brayne C; Ince P; Halliday GM; Kril J; Dalton M; Richardson K; Forster G; Sachdev PS, 2012, 'Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia', Biological Psychiatry, 71, pp. 783 - 791, http://dx.doi.org/10.1016/j.biopsych.2011.07.036
Wong J; Garner B; Halliday G; Kwok J, 2012, 'P4‐372: Evidence of altered TrkB pre‐mRNA splicing in Alzheimer's disease', Alzheimer's & Dementia, 8, http://dx.doi.org/10.1016/j.jalz.2013.08.153
Kavanagh T; Mills JD; Kim WS; Halliday GM; Janitz M, 2012, 'Pathway analysis of the human brain transcriptome in disease', Journal of Molecular Neuroscience, Published online, http://dx.doi.org/10.1007/s12031-012-9940-0
Stevens CH; Rowe DB; Morel-Kopp MC; Orr CF; Russell T; Ranola M; Ward CM; Halliday GM, 2012, 'Reduced T helper and B lymphocytes in Parkinson's disease', Journal of Neuroimmunology, 252, pp. 95 - 99, http://dx.doi.org/10.1016/j.jneuroim.2012.07.015
Lim YA; Giese M; Shepherd CE; Halliday GM; Kobayashi M; Takamatsu K; Staufenbiel M; Eckert A; Gotz J, 2012, 'Role of hippocalcin in mediating Abeta toxicity', Biochimica et Biophysica ACTA - Molecular Basis of Disease, 1822, pp. 1247 - 1257, http://dx.doi.org/10.1016/j.bbadis.2012.04.007
Schwartz RS; Halliday GM; Cordato DJ; Kril JJ, 2012, 'Small-vessel disease in patients with Parkinson's disease: A clinicopathological study', Movement Disorders, 27, pp. 1506 - 1512, http://dx.doi.org/10.1002/mds.25112
Wong JCY; Garner B; Halliday GM; Kwok JBJ, 2012, 'Srp20 regulates TrkB pre-mRNA splicing to generate TrkB-Shc transcripts with implications for Alzheimer's disease', Journal of Neurochemistry, 123, pp. 159 - 171, http://dx.doi.org/10.1111/j.1471-4159.2012.07873.x
Schofield E; Hodges JR; Bak T; Xuereb JH; Halliday GM, 2012, 'The relationship between clinical and pathological variables in Richardson's syndrome', Journal of Neurology, 259, pp. 482 - 490, http://dx.doi.org/10.1007/s00415-011-6205-8
Farrell AW; Halliday GM; Lyons JG, 2011, 'Chromatin structure following UV-induced DNA damage-repair or death?', International Journal of Molecular Sciences, 12, pp. 8063 - 8085, http://dx.doi.org/10.3390/ijms12118063
Bock VL; Lyons JG; Huang XXJ; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM, 2011, 'BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours', British Journal of Dermatology, 164, pp. 1221 - 1227, http://dx.doi.org/10.1111/j.1365-2133.2011.10267.x
Damian DL; Matthews YJ; Phan TA; Halliday GM, 2011, 'An action spectrum for ultraviolet radiation-induced immunosuppression in humans', British Journal of Dermatology, 164, pp. 657 - 659, http://dx.doi.org/10.1111/j.1365-2133.2010.10161.x
Zhou J; Broe M; Huang Y; Anderson JA; Gai WP; Milward EA; Porritt MJ; Howells DW; Hughes AJ; Wang X; Halliday GM, 2011, 'Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson's disease', ACTA Neuropathologica, 121, pp. 695 - 704, http://dx.doi.org/10.1007/s00401-011-0815-1
Sachdev PS; Lee T; Lammel A; Crawford J; Trollor JN; Wright MJ; Brodaty H; Ames D; Martin NG, 2011, 'Cognitive functioning in older twins: The Older Australian Twins Study', Australasian Journal on Ageing, 30, pp. 17 - 23, http://dx.doi.org/10.1111/j.1741-6612.2011.00534.x
Chen-Plotkin A; Martinez-Lage M; Sleiman PMA; Hu W; Greene R; Wood EF; Bing S; Grossman M; Schellenberg GD; Hatanpaa K; Weiner M; White III CL; Brooks WS; Halliday GM; Kril JJ; Gearing M; Beach T; Graff-radford N; Dickson D; Rademakers R; Boeve B; Pickering-Brown SM; Snowden J; Van Swieten JC; Heutink P; Seelaar H; Murrell J; Ghetti B; Spina S; Grafman J; Kaye JA; Woltjer RL; Mesulam M; Bigio EH; Llado A; Miller B; Alzualde A; Moreno FS; Rohrer JD; Mackenzie IRA; Feldman H; Hamilton RL; Cruts M; Engelborghs ; De Deyn PP; Van Broeckhoven C; Bird T; Cairns NJ; Goate A; Frosch MP; Riederer PF; Bogdanovic N; Lee VM; Trojanowski JQ; Van deerlin VM, 2011, 'Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration', Archives of Neurology, 68, pp. 488 - 497
Halliday GM; Stevens C, 2011, 'Glia: Initiators and progressors of pathology in Parkinson's disease', Movement Disorders, 26, pp. 6 - 17, http://dx.doi.org/10.1002/23455
Huang Y; Rowe DB; Halliday , 2011, 'Interaction between a-synuclein and tau genotypes and the progression of Parkinson's disease', Journal of Parkinson's Disease, 1, pp. 271 - 276, http://dx.doi.org/10.3233/JPD-2011-11027
Masters CL; Kril J; Halliday GM; Pamphlett R; Collins S; Hill AF; McLean CA, 2011, 'Overview and recent advances in neuropathology. Part 2: Neurodegeneration', Pathology, 43, pp. 93 - 102, http://dx.doi.org/10.1097/PAT.0b013e3283426eee
Dobson‐Stone C; Luty A; Hallupp M; Coupland K; Brooks W; Panegyres P; Piguet O; Broe GA; Sobow T; Zekanowski C; Halliday G; Schofield P; Kwok J, 2011, 'P1‐285: Sigma non‐opioid intracellular receptor 1 and neurodegeneration: prevalence of mutations and therapeutic implications', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.566
Kwok J; Luty A; Dobson‐Stone C; Loy C; Brooks W; Karlström H; Halliday G; Schofield P, 2011, 'P1‐287: Positional cloning identifies SIGMAR1 gene as a causative locus for FTLD‐MND in a large Australian pedigree', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.568
Kril J; Halliday GM, 2011, 'Pathological staging of frontotemporal lobar degeneration', Journal of Molecular Neuroscience, 45, pp. 379 - 383, http://dx.doi.org/10.1007/s12031-011-9528-0
Byrne SN; Beaugie C; O'Sullivan C; Leighton S; Halliday GM, 2011, 'The Immune-Modulating Cytokine and Endogenous Alarmin Interleukin-33 Is Upregulated in Skin Exposed to Inflammatory UVB Radiation', AMERICAN JOURNAL OF PATHOLOGY, 179, pp. 211 - 222, http://dx.doi.org/10.1016/j.ajpath.2011.03.010
Komadina N; Terpening Z; Huang Y; Halliday GM; Lewis SJG; Naismith S, 2011, 'Utility and limitations of Addenbrooke's cognitive examination-revised for detecting mild cognitive impairment in Parkinson's disease', Dementia and Geriatric Cognitive Disorders, 31, pp. 349 - 357, http://dx.doi.org/10.1159/000328165
Shine JM; Halliday GM; Lewis SJG; Naismith S, 2011, 'Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?', Movement Disorders, 26, pp. 2154 - 2159, http://dx.doi.org/10.1002/mds.23896
Sou PW; Delic NC; Halliday GM; Lyons JG, 2010, 'Snail transcription factors in keratinocytes: Enough to make your skin crawl', International Journal of Biochemistry and Cell Biology, 42, pp. 1940 - 1944, http://dx.doi.org/10.1016/j.biocel.2010.08.021
Gabery S; Murphy K; Schultz K; Loy C; McCusker E; Kirik D; Halliday G; Petersen A, 2010, 'CHANGES IN KEY HYPOTHALAMIC NEUROPEPTIDE POPULATIONS IN HUNTINGTON'S DISEASE REVEALED BY NEUROPATHOLOGICAL ANALYSES', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81, pp. A7 - A8, http://dx.doi.org/10.1136/jnnp.2010.222570.23
Huang Y; Zheng L; Halliday G; Dobson-Stone C; Wang YY; Tang HD; Kowk J; Chen SD, 2010, '78. Genetic influences of sigma-1 receptor and apolipoprotein E on the severity of Alzheimer’s disease', Journal of Clinical Neuroscience, 17, pp. 1633 - 1633, http://dx.doi.org/10.1016/j.jocn.2010.07.079
Van deerlin VM; Sleiman PMA; Martinez-Lage M; Chen-Plotkin A; Wang LS; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Grossman M; Arnold SE; Mann DMA; Pickering-Brown SM; Seelaar H; Heutink P; Van Swieten JC; Murrell JR; Ghetti B; Spina S; Grafman J; Hodges JR; Spillantini MG; Gilman S; Lieberman AP; Kaye JA; Woltjer RL; Bigio EH; Mesulam M; al-Sarraj S; Troakes C; Rosenberg RN; White III CL; Ferrer I; Llado A; Neumann M; Kretzschmar HA; Hulette CM; Welsh-Bohmer KA; Miller BL; Alzualde A; Lopez de Munain A; McKee AC; Gearing M; Levey AI; Lah JL; Hardy J; Rohrer JD; Lashley T; Mackenzie IRA; Feldman HH; Hamilton RL; Dekosky ST; Van der zee ST; Kumar-Singh S; Van Broeckhoven C; Mayeux R; Vonsattel ; Troncoso JC; Kril JJ; Bird T; Halliday GM; Ince PG; Shaw PA; Kwok JB; Cairns NJ; Morris JC; Mclean ; DeCarli C; Ellis WG; Freeman SH; Frosch MP; Growdon JH; Perl DP; Perl DP; Sano DP; Sano M; Bennett DA; Schneider JA; Beach TG; Reiman EM; Woodruff BK; Cummings J; Vinters HV; Miller ; Chui HC; Alafuzoff I; Hartikainen P; Seilhean D; Galasko D; Masliah E; Cotman E; Tunon MT; Martinez MCC; Munoz DG; Carroll SL; Marson SL; Riederer PF; Bogdanovic N; Schellenberg GD; Hakonarson H; Tronjanowski JQ; Lee VMY, 2010, 'Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions', Nature Genetics, 42, pp. 234 - 239
Mitew S; Kirkcaldie MTK; Halliday GM; Shepherd CE; Vickers JC; Dickson TC, 2010, 'Focal demyelination in Alzheimer's disease and transgenic', ACTA Neuropathologica, 119, pp. 567 - 577
Ma M; Huang Y; Chen S; Halliday GM, 2010, 'Immunohistochemical evidence for macroautophagy in neurons and endothelial cells in Alzheimer's disease', Neuropathology and Applied Neurobiology, 36, pp. 312 - 319
Kim WS; Bhatia S; Elliott DA; Agholme L; Kagedal K; Mccann H; Halliday GM; Barnham K; Garner B, 2010, 'Increased ATP-binding cassette trabsporter A1 expression in Alzheimer's disease hippocampal neurons', Journal of Alzheimer's Disease, 21, pp. 193 - 205
Kagedal K; Kim WS; Appelqvist A; Chan LL; Cheng D; Agholme L; Barnham K; Mccann H; Halliday GM; Garner B, 2010, 'Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease', Biochimica et Biophysica ACTA - Molecular and Cell Biology of Lipids, 1801, pp. 831 - 838
Schofield E; Halliday GM; Kwok J; Loy C; Double KL; Hodges JR, 2010, 'Low serum progranulin predicts the presence of mutations: a prospective study', Journal of Alzheimer's Disease, 22, pp. 981 - 984
Obeso J; Rodriguez-oroz M; Goetz CG; Marin C; Kordower J; Rodriguez M; Hirsch E; Farrer M; Schapira A; Halliday GM, 2010, 'Missing pieces in the Parkinson's disease puzzle', Nature Medicine, 16, pp. 653 - 661
Mackenzie IRA; Neumann M; Bigio EH; Cairns NJ; Alafuzoff I; Kril J; Kovacs G; Ghetti B; Halliday GM; Holm IE; Ince PG; Kamphorst W; Revesz T; Rozemuller AJM; Kumar-Singh S; Akiyama H; Baborie A; Spina S; Dickson D; Trojanowski JQ; Mann DMA, 2010, 'Nomenclature and nosology for neurophathologic subtypes of frontotemporal lobar degeneration: an update', ACTA Neuropathologica, 119, pp. 1 - 4